Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of CHF 5074 in Healthy Young Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2015
At a glance
- Drugs CHF 5074 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chiesi
- 18 Aug 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 18 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2010 Tolerability and interim pharmacokinetic results presented at the 2010 International Conference on Alzheimer's Disease
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History